Evidence map›Paper›PMID 37482382›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2023

An evaluation of neuropsychiatric manifestations in systemic lupus erythematosus patients in Saudi Arabia and their associated factors.

Yousef M Alammari, Mahmoud A Gaddoury, Abdullah A Alaryni, Abdullah H Alghamdi, Sara A Alharbi, Reem A Almohaini, Lena S Alsaleem, Lujain H Allowaihiq, Maha H Alrashid

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yousef M AlammariFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0002-5318-4689
Mahmoud A GaddouryFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Abdullah A AlaryniFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Abdullah H AlghamdiFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Sara A AlharbiFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Reem A AlmohainiFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Lena S AlsaleemFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Lujain H AllowaihiqFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
Maha H AlrashidFrom the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo establish the prevalence of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) symptoms in Saudi Arabia and the variables that are linked to it.

methodsThis cross-sectional study was conducted in June 2021 among SLE patients in Saudi Arabia. The Saudi Rheumatism Association exploited social media platforms to provide a self-administered online questionnaire to SLE patients. All data analyses were performed using the Statistical Packages for Social Sciences (SPSS) version 26.

resultsTwo hundred and eight SLE patients participated in the study (females 91.3% vs. males 8.7%). In addition, 13.5% of patients had a family history of SLE, and 26% had SLE for one to 3 years. The most common symptoms of NPSLE were alteration or loss of sensation (53.4%), followed by fear (52.4%), and headache (48.1%). The prevalence of patients with NPSLE was 40%. In a multivariate regression model, fear, altered sensations, cerebrovascular illness, sleep disruption, and diminished interest in routine activities were identified as independent risk variables for NPSLE

conclusionNearly half of SLE patients demonstrated NP manifestations, with significant symptoms including fear, alteration of sensation, cerebrovascular disease, sleep disturbance, and reduced interest in normal activities. To detect the pathophysiology of NPSLE, it is necessary to understand the relationship between neuropsychiatric morbidity and other relevant rheumatic disorders in the SLE population.

Indexed as

Lupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemCross-Sectional StudiesFemaleHeadacheHumansMaleSaudi Arabia

Identifiers

PMID37482382
PMCPMC10519659
OpenAlexW4385175265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.